HealthSaaS · CarePath Distributed Care Model · RHTP Clinical Framework

VEMA Applied to CarePath / RHTP

A structured clinical communication framework for Tele-Navigator patient engagement. Click any element to explore the touchpoints, tools, and evidence behind each phase.

V — Validation

Build trust before anything else

Rural and dual-eligible patients arrive with a history of fragmented, dismissive, or inaccessible care. Validation acknowledges that reality explicitly — establishing the safety and rapport that make education, motivation, and activation possible. Without it, nothing downstream lands.

CarePath Touchpoints — Click to Explore

↖

Select a touchpoint
to see details, tools,
and example language

RHTP outcome connection

54%

Fewer hospital admissions

Technology to Support Aging in Place (TSAP)

Demonstrated in the Technology to Support Aging in Place (TSAP) program in Southwest Washington with dual-eligible heart failure patients. Sustained longitudinal navigator relationships — producing validated, educated, motivated, activated patients — drove this outcome. This is the evidence base CarePath replicates at RHTP scale.

57%

Fewer hospital days

Technology to Support Aging in Place (TSAP)

Reduction in total inpatient days for dual-eligible heart failure patients in the Technology to Support Aging in Place (TSAP) cohort. Combined with the 54% admission reduction, this represents a shift from reactive crisis management to proactive self-management — the mechanism VEMA enables at scale.

Lower TCO

Total cost of care — dual-eligible / Medicaid populations

Value-based care evidence base

Activated patients (PAM level 3–4) generate significantly lower total cost of care through reduced ED utilization, fewer hospitalizations, and better medication adherence. For dual-eligible and Medicaid populations across all RHTP states, this cost reduction is the financial foundation of the CarePath APM payment model.